trending Market Intelligence /marketintelligence/en/news-insights/trending/PLJanunTLPhaYoPL_H5qNw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Hong Kong's PuraPharm to acquire Japanese health products company

COVID-19 Impact & Recovery: Corporations

Blog

COVID-19 Impact & Recovery: Investment Banking

Blog

COVID-19 Impact & Recovery: Governments

Blog

COVID-19 Impact & Recovery: Academia


Hong Kong's PuraPharm to acquire Japanese health products company

PuraPharm Corp. Ltd., through its Japanese unit, signed a share purchase agreement to acquire health food manufacturer and seller SODX Co. Ltd. in a deal worth ¥244 million.

Under the deal, SODX will become an indirect wholly owned subsidiary of the Hong Kong-based Chinese medicine company.

PuraPharm will use SODX's factory as a pilot facility to transfer technological know-how from Japan to help improve quality and production efficiency of PuraPharm Chinese healthcare products. PuraPharm will also use the pilot factory as a new product development center for business expansion.

SODX produces its own branded products and makes health products and packaging specified by its customers.

As of Aug. 14, US$1 was equivalent to ¥109.46.